Fernandez A, Chen P W, Ananthaswamy H N
Department of Immunology, University of Texas M.D. Anderson Cancer Center, Houston 77030.
Anticancer Res. 1994 Nov-Dec;14(6B):2649-52.
Tumor necrosis factor (TNF) is toxic to many tumor cells but not to normal cells. We previously reported that transfection of TNF-resistant C3H10T1/2 fibroblasts with a mutant Ha-ras oncogene induced tumorigenicity as well as TNF sensitivity. To investigate the relationship between tumorigenic transformation and TNF sensitivity, we isolated TNF-resistant revertants from Ha-ras transformed TNF-sensitive cells and analyzed them for p21 expression and tumorigenic potential. The TNF-resistant cells expressed the same amount of mutant p21 as TNF-sensitive cells and retained their tumorigenic potential. In fact, TNF-resistant cells were more tumorigenic than TNF-sensitive cells. These results suggest that mutant p21 expression is directly associated with tumorigenic transformation, while acquisition of TNF sensitivity is incidental to the process of neoplastic transformation. It is possible, however, that ras-induced TNF sensitivity and transformation are regulated by different effector molecules downstream of Ras.
肿瘤坏死因子(TNF)对许多肿瘤细胞具有毒性,但对正常细胞无毒性。我们先前报道,用突变的Ha-ras癌基因转染对TNF耐药的C3H10T1/2成纤维细胞可诱导致瘤性以及TNF敏感性。为了研究致瘤性转化与TNF敏感性之间的关系,我们从Ha-ras转化的TNF敏感细胞中分离出对TNF耐药的回复子,并分析它们的p21表达和致瘤潜力。TNF耐药细胞表达的突变型p21量与TNF敏感细胞相同,并保留了它们的致瘤潜力。事实上,TNF耐药细胞比TNF敏感细胞更具致瘤性。这些结果表明,突变型p21表达与致瘤性转化直接相关,而TNF敏感性的获得是肿瘤转化过程中的偶然现象。然而,ras诱导的TNF敏感性和转化可能受Ras下游不同效应分子的调节。